It was pretty easy to figure out from day one of https://www.marketwatch.com/press-release/mydx-seeks-medical-device-designation-for-cannadx-and-the-ecosmartpen-2017-12-14-920200 that December 14, 2017 PR ..... .....today announced it submitted an application and is seeking medical device designation in Canada for its CannaDx(TM) Handheld Tester and its ECOSmartPen(TM).... Those are two separate things, made to look like the application submission was for the medical device designation. Confirmation came in https://www.otcmarkets.com/filing/html?id=12688781&guid=z4YSUpA5J_oWWth the 10-K a few months later..... On April 1, 2018, the Company verbally agreed to enter into an agreement to appoint Dr. Heiner Dreismann to its business advisory board to assist the Company’s management with evaluating potential merger and acquisition opportunities, developing a plan to secure a medical device designation from Health Canada for CannaDx, and other advice related to the Company’s business. Why would a plan be developed after an application was already submitted?